scholarly journals Enhancing the Sensitivity of Memory Tests: Reference Data for the Free and Cued Selective Reminding Test and the Logical Memory Task from Cognitively Healthy Subjects with Normal Alzheimer’s Disease Cerebrospinal Fluid Biomarker Levels

2021 ◽  
pp. 1-10
Author(s):  
Anna Brugulat-Serrat ◽  
Alba Cañas ◽  
Lidia Canals ◽  
Paula Marne ◽  
Nina Gramunt ◽  
...  

Background: Cognitive performance of a given individual should be interpreted in the context of reference standards obtained in cognitively healthy populations. Recent evidence has shown that removing asymptomatic individuals with biomarker evidence of Alzheimer’s disease (AD) pathology from normative samples increases the sensitivity of norms to detect memory impairments. These kind of norms may be useful for defining subtle cognitive decline, the transitional cognitive decline between normal cognition and mild cognitive impairment. Objective: The present study aims to provide norms for the Free and Cued Selective Reminding Test (FCSRT) and the Logical Memory subtest of the Wechsler Memory Scale-IV in a sample of individuals aged 50–70 years with normal levels of amyloid (A) and tau (T) cerebrospinal fluid (CSF) biomarkers. Methods: The sample was composed of 248 individuals from the ALFA+ study with negative amyloid-β and tau CSF biomarker levels. Regression-based norms were developed, including adjustments for age, education, and sex when applicable. Results: We found that education was associated with the performance in all the variables of both tests while age had a marginal effect only in the delayed free recall of the FCSRT. Sex was also related to the performance in the FCSRT, with women outperforming men. Equations to calculate z-scores and normative percentile tables were created. As compared with previously published norms the reference data presented were more sensitive but less specific, as expected. Conclusion: The use of the norms provided in this work, in combination with the already published conventional norms, may contribute to detecting subtle memory impairment.

2017 ◽  
Vol 61 (2) ◽  
pp. 589-600 ◽  
Author(s):  
Andrea Slachevsky ◽  
Paulo Barraza ◽  
Michael Hornberger ◽  
Carlos Muñoz-Neira ◽  
Emma Flanagan ◽  
...  

2010 ◽  
Vol 19 (4) ◽  
pp. 1143-1148 ◽  
Author(s):  
Cristoforo Comi ◽  
Miryam Carecchio ◽  
Annalisa Chiocchetti ◽  
Stefania Nicola ◽  
Daniela Galimberti ◽  
...  

2020 ◽  
Vol 77 (3) ◽  
pp. 1143-1155
Author(s):  
Daniela Enache ◽  
Joana B. Pereira ◽  
Vesna Jelic ◽  
Bengt Winblad ◽  
Per Nilsson ◽  
...  

Background: Cognitive deficits arising in the course of Alzheimer’s disease (AD), dementia with Lewy bodies (DLB), and Parkinson’s disease with dementia (PDD) are directly linked to synaptic loss. Postmortem studies suggest that zinc transporter protein 3 (ZnT3), AMPA glutamate receptor 3 (GluA3), and Dynamin1 are associated with cognitive decline in AD and Lewy body dementia patients. Objective: We aimed to evaluate the diagnostic value of ZnT3, GluA3, and Dynamin 1 in the cerebrospinal fluid (CSF) of patients with dementia due to AD, DLB, and PDD compared to cognitively normal subjective cognitive decline (SCD) patients in a retrospective study. In addition, we assessed the relationship between synaptic markers and age, sex, cognitive impairment, and depressive symptoms as well as CSF amyloid, phosphorylated tau (p-tau), and total tau (T-tau). Methods: Commercially available ELISA immunoassay was used to measure the levels of proteins in a total of 97 CSF samples from AD (N = 24), PDD (N = 18), DLB (N = 27), and SCD (N = 28) patients. Cognitive impairment was assessed using the Mini-Mental State Examination (MMSE). Results: We found a significant increase in the concentrations of ZnT3, GluA3, and Dynamin1 in AD (p = 0.002) and of ZnT3 and Dynamin 1 in DLB (p = 0.001, p = 0.002) when compared to SCD patients. Changes in ZnT3 concentrations correlated with MMSE scores in AD (p = 0.011), and with depressive symptoms in SCD (p = 0.041). Conclusion: We found alteration of CSF levels of synaptic proteins in AD, PDD, and DLB. Our results reveal distinct changes in CSF concentrations of ZnT3 that could reflect cognitive impairment in AD with implications for future prognostic and diagnostic marker development.


PLoS ONE ◽  
2014 ◽  
Vol 9 (12) ◽  
pp. e114777 ◽  
Author(s):  
Ying Liu ◽  
Jin-Tai Yu ◽  
Hui-Fu Wang ◽  
Xiao-Ke Hao ◽  
Yu-Fen Yang ◽  
...  

2012 ◽  
Vol 33 (24) ◽  
pp. 3738-3744 ◽  
Author(s):  
Valentina Albertini ◽  
Luisa Benussi ◽  
Anna Paterlini ◽  
Michela Glionna ◽  
Annapaola Prestia ◽  
...  

2018 ◽  
Vol 59 (5) ◽  
pp. 496-502 ◽  
Author(s):  
Asmus Vogel ◽  
Jette Stokholm ◽  
Rikke Andreasen ◽  
Bodil Dahl Henriksen ◽  
Vibeke Brønniche ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document